ERIN DIAZ: Open Payments
NPI 1295447688 · PLANT CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$358 in 14 payments from 10 companies in 2025. Trend: 2023 $148 · 2024 $162 · 2025 $358
Food & beverage: $358
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 3 | $92 |
| PFIZER INC. | 3 | $67 |
| Galderma Laboratories, L.P. | 1 | $38 |
| Novartis Pharmaceuticals Corporation | 1 | $27 |
| Organon LLC | 1 | $26 |
| Janssen Biotech, Inc. | 1 | $26 |
| ABBVIE INC. | 1 | $25 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| Amgen Inc. | 1 | $19 |
| Incyte Corporation | 1 | $16 |
Products named: DUPIXENT, CIBINQO, NEMLUVIO, TREMFYA, SKYRIZI, Otezla, Opzelura.
Industry payments across FL — which companies pay providers there.
